Gillies Hunter's Form 4 filing
Jade Biosciences, Inc. (JBIO) · filed Dec 15, 2023
- Accession no.
- 0001415889-23-016539
- Filed
- Dec 15, 2023
- Trade date
- Dec 13-14, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 4 derivative transactions. Open-market sales total $234.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gillies HunterCIK 0001868997 | Officer (CHIEF MEDICAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2023 | Common Stock | MOption exerciseAcquired | +2,103 | $1.74 | +$3,659.22 | 5,354 | Direct | |
| Dec 13, 2023 | Common Stock | SSaleDisposed | −2,103 | $19.50 | −$41,008.5 | 3,251 | Direct | |
| Dec 14, 2023 | Common Stock | MOption exerciseAcquired | +9,897 | $1.74 | +$17,220.78 | 13,148 | Direct | |
| Dec 14, 2023 | Common Stock | SSaleDisposed | −9,897 | $19.50 | −$192,991.5 | 3,251 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2023 | Common Stock | MOption exerciseDisposed | −653 | $0.00 | $0 | 15,444 | Direct | |
| Dec 13, 2023 | Common Stock | MOption exerciseDisposed | −1,450 | $0.00 | $0 | 17,503 | Direct | |
| Dec 14, 2023 | Common Stock | MOption exerciseDisposed | −2,700 | $0.00 | $0 | 12,744 | Direct | |
| Dec 14, 2023 | Common Stock | MOption exerciseDisposed | −7,197 | $0.00 | $0 | 10,306 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.